Business Context and Reporting Period
Company: Compugen Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 19, 2025
Reporting Period: First Quarter 2025
This filing serves as a conduit for the Company's press release dated May 19, 2025, which details the financial results for the first quarter of 2025. The press release is incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided Form 6-K text acts as a cover document and does not contain specific financial data points. The following metrics are not present in the filing text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Specific values for these metrics are contained within the referenced Press Release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide comparative data or describe material changes versus the prior comparable period. Investors must refer to the full text of the First Quarter 2025 Press Release for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. The document explicitly states that information from the Press Release is incorporated by reference, except for quotes attributable to Anat Cohen-Dayag, Ph.D.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the attached Press Release (Exhibit 99.1).
- Confirm the cash balance and burn rate as of March 31, 2025.
- Review the status of the Company's clinical programs and any updates on regulatory milestones.
- Check for any new debt instruments or equity issuances mentioned in the full press release.
- Assess the liquidity runway based on the Q1 2025 cash position.